Application 219159
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLIPIZIDE | GLIPIZIDE | TABLET;ORAL | 5MG | No | No |
| 002 | GLIPIZIDE | GLIPIZIDE | TABLET;ORAL | 10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219159-001 | GLIPIZIDE | GLIPIZIDE | 5MG | TABLET / ORAL | AB | 2026-03-04 | |
| A219159-002 | GLIPIZIDE | GLIPIZIDE | 10MG | TABLET / ORAL | AB | 2026-03-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219159-001 | AB |
| A219159-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219159-001 | GLIPIZIDE | 5MG | TABLET / ORAL | AB | 2026-03-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219159-002 | GLIPIZIDE | 10MG | TABLET / ORAL | AB | 2026-03-04 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219159-001 | GLIPIZIDE | 5MG | TABLET / ORAL | AB | 2026-03-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219159-002 | GLIPIZIDE | 10MG | TABLET / ORAL | AB | 2026-03-04 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219159-001 | GLIPIZIDE | 5MG | TABLET / ORAL | AB | 2026-03-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219159-002 | GLIPIZIDE | 10MG | TABLET / ORAL | AB | 2026-03-04 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219159-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219159-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219159-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219159-002 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219159-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219159-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | c8cfd137-7b41-460f-a463-141c9d1985ff | 2026-06-04 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | St. Mary's Medical Park Pharmacy | 0ccc17ca-fff8-0449-e063-6294a90af36d | 2026-06-03 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | 9b405ff3-6ce5-460a-9406-db92e0e6ab1b | 2026-05-21 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 69a21bd3-3364-4035-b098-3808cc8cf8b2 | 2026-05-17 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | c582d7d0-4db0-4296-8131-baefd1a671b2 | 2026-05-17 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Coupler LLC | 51b35391-7672-c02f-e063-6294a90af54e | 2026-05-13 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | 2aa01a7e-a703-426f-9cd3-70b88d0a8e7f | 2026-05-13 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Cardinal Health 107, LLC | bf1f5a5d-79b0-4fc5-96f2-bd5119b56e2a | 2026-05-08 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals Inc.. | 02857195-33e9-4c1f-9e5f-7cc62f283649 | 2026-05-07 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals Inc. | 548c1f50-dbf0-49cc-b58b-fcc5937affa8 | 2026-05-07 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals Inc. | 4632b4ec-d2f1-40cc-8ef4-256413d8dbec | 2026-05-06 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals, Inc. | 097424ef-612f-4bc2-809a-e5bb8eeae244 | 2026-05-06 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Preferred Pharmaceuticals Inc. | 65ddb8b3-19d4-482f-8aec-49dc167a4c40 | 2026-05-06 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | ceb86ebb-d00a-4261-90ad-8751e799d93c | 2026-04-20 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 99af53db-e102-427a-a5a2-be1e69b3152d | 2026-04-16 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | 4afa67b2-7f86-4189-93a5-6a605f74540d | 2026-04-09 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | a34b58ac-42b2-4a19-a28b-cb3144ea55cd | 2026-03-26 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Major Pharmaceuticals | d3b5677c-2265-47c8-beeb-bf12106056ba | 2026-03-13 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Advagen Pharma Limited | e954afb8-52eb-416a-8f1b-14b0fcb3bac2 | 2026-03-06 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Glipizide | GLIPIZIDE | Legacy Pharmaceutical Packaging, LLC | 116ffc6a-735c-49e0-a9d5-69b6bc3e3706 | 2026-03-03 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.